Research ExplorerScientific StaffKatja Weisel Publications

Prof.Dr.med. ID: 6488383

Katja Weisel

graph of relations
Affiliations
201 - 244 out of 244Page size: 50

Publications

  1. 2014

  2. Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

    Scheid, C., Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Blau, I. W., Vellenga, E., Weisel, K., Pfreundschuh, M., Jie, K-S., Neben, K., van de Velde, H., Duehrsen, U., Schaafsma, M. R., Lindemann, W., Kersten, M. J., Peter, N., Hänel, M., Croockewit, S., Martin, H., Wittebol, S., Bos, G. M., van Marwijk-Kooy, M., Wijermans, P., Goldschmidt, H. & Lokhorst, H. M., 01.2014, In: HAEMATOLOGICA. 99, 1, p. 148-54 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study

    Schulze, M., Weisel, K., Grandjean, C., Oehrlein, K., Zago, M., Spira, D. & Horger, M., 01.2014, In: AM J ROENTGENOL. 202, 1, p. 170-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2013

  5. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Miguel, J. S., Weisel, K., Moreau, P., Lacy, M., Song, K., Delforge, M., Karlin, L., Goldschmidt, H., Banos, A., Oriol, A., Alegre, A., Chen, C., Cavo, M., Garderet, L., Ivanova, V., Martinez-Lopez, J., Belch, A., Palumbo, A., Schey, S., Sonneveld, P., Yu, X., Sternas, L., Jacques, C., Zaki, M. & Dimopoulos, M., 10.2013, In: LANCET ONCOL. 14, 11, p. 1055-1066 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic data

    Pintoffl, J. P., Weisel, K., Schulze, M., Maksimovic, O., Claussen, C. D., Kramer, U. & Horger, M., 10.2013, In: J ULTRAS MED. 32, 10, p. 1777-88 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas

    Adam, P., Baumann, R., Schmidt, J., Bettio, S., Weisel, K., Bonzheim, I., Fend, F. & Quintanilla-Martínez, L., 09.2013, In: HUM PATHOL. 44, 9, p. 1817-26 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Cutaneous presentation of hematological malignancies

    Eberle, F. C., Metzler, G., Weisel, K. C., Berneburg, M. & Yazdi, A. S., 21.06.2013, In: EUR J DERMATOL. 23, 3, p. 372-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2012

  10. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial

    Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., El Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., Weisel, K. C., Wittebol, S., Bos, G. M. J., Stevens-Kroef, M., Scheid, C., Pfreundschuh, M., Hose, D., Jauch, A., van der Velde, H., Raymakers, R., Schaafsma, M. R., Kersten, M-J., van Marwijk-Kooy, M., Duehrsen, U., Lindemann, W., Wijermans, P. W., Lokhorst, H. M. & Goldschmidt, H. M., 20.08.2012, In: J CLIN ONCOL. 30, 24, p. 2946-55 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation

    Guthoff, M., Schmid-Horch, B., Weisel, K. C., Häring, H-U., Königsrainer, A. & Heyne, N., 06.2012, In: TRANSPL IMMUNOL. 26, 4, p. 171-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers

    Oehrlein, K., Langer, C., Sturm, I., Pönisch, W., Hahn-Ast, C., Kuhn, S. & Weisel, K. C., 06.2012, In: CL LYMPH MYELOM LEUK. 12, 3, p. 191-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

    Auel, B., Goldschmidt, H., Geer, T., Moehler, T. M., Platzbecker, U., Naumann, R., Blau, I., Hänel, M., Knauf, W., Nückel, H., Salwender, H-J., Scheid, C., Weisel, K., Gorschlüter, M., Glasmacher, A., Schmidt-Wolf, I. G. H. & German Refractory Myeloma Study Group, 06.2012, In: INDIAN J HEMATOL BLO. 28, 2, p. 67-76 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Continuous lenalidomide treatment for newly diagnosed multiple myeloma

    Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C., Ben Yehuda, D., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C., Dimopoulos, M. A. & MM-015 Investigators, 10.05.2012, In: NEW ENGL J MED. 366, 19, p. 1759-69 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

    Heyne, N., Denecke, B., Guthoff, M., Oehrlein, K., Kanz, L., Häring, H-U. & Weisel, K. C., 05.2012, In: ANN HEMATOL. 91, 5, p. 729-735 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

    Neben, K., Lokhorst, H. M., Jauch, A., Bertsch, U., Hielscher, T., van der Holt, B., Salwender, H., Blau, I. W., Weisel, K., Pfreundschuh, M., Scheid, C., Dührsen, U., Lindemann, W., Schmidt-Wolf, I. G. H., Peter, N., Teschendorf, C., Martin, H., Haenel, M., Derigs, H. G., Raab, M. S., Ho, A. D., van de Velde, H., Hose, D., Sonneveld, P. & Goldschmidt, H., 26.01.2012, In: BLOOD. 119, 4, p. 940-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?

    Spira, D., Weisel, K., Brodoefel, H., Schulze, M., Kaufmann, S. & Horger, M., 01.2012, In: ACAD RADIOL. 19, 1, p. 89-94 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Osteoprotegerin positively regulates hematopoietic progenitor cells

    Schweikle, E., Baessler, T., Yildirim, S., Kanz, L., Möhle, R. & Weisel, K. C., 01.2012, In: CURR STEM CELL RES T. 7, 1, p. 72-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2011

  20. Modern imaging techniques during therapy in patients with multiple myeloma

    Horger, M., Weisel, K., Bares, R., Ernemann, U., Claussen, C. D., Lichy, M. & Fenchel, M., 01.10.2011, In: ACTA RADIOL. 52, 8, p. 881-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results

    Horger, M., Weisel, K., Horger, W., Mroue, A., Fenchel, M. & Lichy, M., 06.2011, In: AM J ROENTGENOL. 196, 6, p. W790-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2010

  23. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results

    Fenchel, M., Konaktchieva, M., Weisel, K., Kraus, S., Brodoefel, H., Claussen, C. D. & Horger, M., 12.2010, In: EUR RADIOL. 20, 12, p. 2899-906 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility study

    Fenchel, M., Konaktchieva, M., Weisel, K., Kraus, S., Claussen, C. D. & Horger, M., 11.2010, In: ACAD RADIOL. 17, 11, p. 1326-33 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Imaging findings in relapsing multiple myeloma

    Sauter, A., Weisel, K. & Horger, M., 08.2010, In: BRIT J HAEMATOL. 150, 4, p. 388

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells

    Weisel, K. C., Kopp, H-G., Moore, M. A. S., Studer, L. & Barberi, T., 05.2010, In: STEM CELLS DEV. 19, 5, p. 745-51 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas

    Weidmann, E., Hess, G., Chow, K. U., Krause, S. W., Subklewe, M., Kruse, J., Weisel, K. C., Soekler, M., Kim, S-Z., Napieralski, S., Rech, J., Dreyling, M., Jäger, E. & Mitrou, P. S., 03.2010, In: LEUKEMIA LYMPHOMA. 51, 3, p. 447-55 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 2009

  29. DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

    Kropff, M., Liebisch, P., Knop, S., Weisel, K., Wand, H., Gann, C-N., Berdel, W. E., Einsele, H. & Deutsche Studiengruppe Multiples Myelom, DSMM, 11.2009, In: ANN HEMATOL. 88, 11, p. 1125-30 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Severe psychotic disorder and agranulocytosis--a therapeutic dilemma

    Borbé, R., Weisel, K., Sachs, U. J. H. & Steinert, T., 11.2009, In: PHARMACOPSYCHIATRY. 42, 6, p. 284-5 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Rhabdomyolysis and acute kidney injury

    Heyne, N., Guthoff, M. & Weisel, K. C., 01.10.2009, In: NEW ENGL J MED. 361, 14, p. 1412; author reply 1412-3

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008

    Weisel, K. C., Dick, J., Fibbe, W. E. & Kanz, L., 09.2009, In: ANN NY ACAD SCI. 1176, p. 1-17 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease

    Vogel, M. N., Weisel, K., Maksimovic, O., Peters, S., Brodoefel, H., Claussen, C. D. & Horger, M. S., 09.2009, In: AM J ROENTGENOL. 193, 3, p. 656-61 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

    Kopp, H. G., Yildirim, S., Weisel, K. C., Kanz, L. & Vogel, W., 04.2009, In: J CANCER RES CLIN. 135, 4, p. 637-42 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support

    Weisel, K. C., Moore, M. A. S., Kanz, L. & Möhle, R., 03.2009, In: STEM CELLS DEV. 18, 2, p. 229-34 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells

    Weisel, K. C., Yildirim, S., Schweikle, E., Kanz, L. & Möhle, R., 03.2009, In: ANN HEMATOL. 88, 3, p. 203-11 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide

    Weisel, K. C., Böckeler, M., Bianchi, L., Terracciano, L. M., Mayer, F. & Kanz, L., 01.2009, In: International journal of hematology. 89, 1, p. 91-94 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Modulation of CXC chemokine receptor expression and function in human neutrophils during aging in vitro suggests a role in their clearance from circulation

    Weisel, K. C., Bautz, F., Seitz, G., Yildirim, S., Kanz, L. & Möhle, R., 2009, In: MEDIAT INFLAMM. 2009, p. 790174

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 2008

  40. Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma

    Weisel, K. C., Weidmann, E., Anagnostopoulos, I., Kanz, L., Pezzutto, A. & Subklewe, M., 11.2008, In: International journal of hematology. 88, 4, p. 434-440 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells

    Ji, J., Vijayaragavan, K., Bosse, M., Menendez, P., Weisel, K. & Bhatia, M., 10.2008, In: Stem cells (Dayton, Ohio). 26, 10, p. 2485-95 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial

    Hutchison, C. A., Cook, M., Heyne, N., Weisel, K., Billingham, L., Bradwell, A. & Cockwell, P., 28.09.2008, In: TRIALS. 9, p. 55

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. 2007

  44. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells VI, University of Tübingen, Germany, September 14-16, 2006

    Weisel, K. C., Fibbe, W. E. & Kanz, L., 07.2007, In: Experimental hematology. 35, 7, p. 1005-14 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  45. Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities

    Xue, X., Cai, Z., Seitz, G., Kanz, L., Weisel, K. C. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 180-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  46. Effect of FLT3 inhibition on normal hematopoietic progenitor cells

    Weisel, K. C., Yildirim, S., Schweikle, E., Kanz, L. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 190-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  47. 2006

  48. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma

    Hartmann, J. T., Meisinger, I., Kröber, S. M., Weisel, K., Klingel, K. & Kanz, L., 12.2006, In: HAEMATOLOGICA. 91, 12 Suppl, p. ECR49

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis

    Weisel, K. C., Gao, Y., Shieh, J-H. & Moore, M. A. S., 11.2006, In: Experimental hematology. 34, 11, p. 1505-16 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 2005

  51. Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region

    Weisel, K. C. & Moore, M. A. S., 06.2005, In: ANN NY ACAD SCI. 1044, p. 51-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  52. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells V, University of Tübingen, Germany, September 16-18, 2004

    Weisel, K. C., Brümmendorf, T. H., Orlic, D., Fibbe, W. E. & Kanz, L., 05.2005, In: Experimental hematology. 33, 5, p. 513-22 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  53. 2004

  54. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication

    Gammaitoni, L., Weisel, K. C., Gunetti, M., Wu, K-D., Bruno, S., Pinelli, S., Bonati, A., Aglietta, M., Moore, M. A. S. & Piacibello, W., 15.06.2004, In: BLOOD. 103, 12, p. 4440-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders

    Weisel, K. C., Brugger, W., Kröber, S. M., Kaiserling, E. & Kanz, L., 2004, In: HEMATOL J. 5, 5, p. 444-6 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next